• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Intensive Care . Endothelial glycocalyx shedding in the acute respiratory distress syndrome after flu syndrome

tetano

Editor, Senior Moderator
J Intensive Care


. 2020 Sep 21;8:72.
doi: 10.1186/s40560-020-00488-7. eCollection 2020.
Endothelial glycocalyx shedding in the acute respiratory distress syndrome after flu syndrome


Maira Nilson Benatti[SUP] 1 [/SUP], Alexandre Todorovic Fabro[SUP] 2 [/SUP], Carlos Henrique Miranda[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Scientific evidence indicates that endothelial glycocalyx (EG) shedding contributes to the pathophysiological installation of acute respiratory distress syndrome (ARDS) after bacterial sepsis. The aim was to evaluate the EG shedding in ARDS installation after flu syndrome.
Methods: This cross-sectional study included patients with flu syndrome during the influenza outbreak divided into two groups: patients with and without ARDS. Healthy subjects without flu syndrome were included in a control group. We measured EG damage biomarkers (hyaluronan, syndecan-1) and endothelial cell injury biomarker (soluble thrombomodulin) during the first medical evaluation. Histological assessment of the perimeter of the hyaline membrane and the number of neutrophils infiltrated in the alveolar septum was performed in patients who died.
Results: ARDS group had 30 patients (44 ? 16 years old, 57% men), the non-ARDS group had 36 patients (39 ? 17 years old, 42% men), and the control group had 35 individuals (44 ? 9 years old, 51% men). Hyaluronan levels were significantly higher in the ARDS group than the two groups [31 ng/ml (interquartile range-IQR 12-56) vs. 5 ng/ml (IQR 3-10) vs. 5 ng/ml (IQR 2-8); p < 0.0001]. Hyaluronan levels above 19 ng/ml in patients with flu syndrome were associated with a significant increase in 28-day mortality rate: relative risk (RR): 6.95; (95% confidence interval 1.88-25.67); p = 0.0017. A positive correlation was observed between hyaline membrane perimeter and soluble thrombomodulin levels (r = 0.89; p = 0.05) as well as between the number of neutrophils in the alveolar septum and hyaluronan levels (r = 0.89; p = 0.05).
Conclusions: Evidence of EG shedding was found in ARDS established after flu syndrome.

Keywords: Acute respiratory distress syndrome; Endothelial glycocalyx; Hyaluronic; Influenza virus.
 
Back
Top Bottom